Market Scenario
Global Chemiluminescence Immunoassay market garnered revenue US$ 7.50 billion in 2020 and is predicted to reach revenue US$ 16.24 billion by the end of 2030, by recording notable compound annual growth rate (CAGR) of 8.03% during forecast period 2021 to 2030. Market Growth Impacting Factors Chemiluminescence immunoassay (CLIA) has been extensively applied in diverse fields such as liquid chromatography, environmental monitoring, food safety, clinical diagnosis, immuno- and gene probe assays, and pharmaceutical analysis. It is applied in these areas as a promising tactic for sensitive, rapid, selective and simple analysis. It is essential to perceive a huge number of low-abundance or complicated samples. Though, outdated methods require excessive time, labor and reagents that restrain their clinical applications. As a result, high-throughput, rapid, low-cost detection and sensitive methods have become the development trend of CLIA. The global chemiluminescence immunoassay market is driven by few notable factors such as: Swift surge in the COVID-19 cases, the responsiveness regarding timely medical attention, and speedily refining healthcare infrastructure in terms of quick testing, which in turn, enhancing the growth of chemiluminescence immunoassay industry. Unhealthy diet and sedentary lifestyle are propagating pervasiveness & occurrence of chronic diseases. For case, as per data released by World Health Organization (WHO), in 2018 cancer burden was increased to 18.1 million new cases and 9.6 million deaths across the world. COVID 19 Impact on market Landscape COVID-19 has emerged as pandemic disease caused due to infection with SARS-CoV-2 virus. Diagnosis of acute disease in the medical laboratory significantly depends on RT-PCR testing, serological testing for antibodies precisely directed against viral proteins of SARS-CoV2. Currently, numerous tests dependent on chemiluminescence immunoassay techniques have become accessible to test for SARS-CoV-2 antibodies. The COVID-19 epidemic has been critical in shaping the clinical diagnostic sector research into the development of molecular diagnostic and assays research. Imperative necessity to aid the growth of these diagnostic devices to restrain the influence and the spread of the virus is the foremost area of focus for the principal manufacturers. Numerous CLIA kits have been proven to offer speedy results with sensitivity rates among the ranges of 64% and 97%. Segment Analysis Product Insights Among different product segments, consumables segment conquered the market with a share of around 64% in 2021 and is predicted to preserve its lead during years to come. This growth is dedicated to the augmented need for consumables including reagents and stains, in the area of endocrinology, therapeutic drug monitoring, and disease diagnosis. Endocrine Disorder Segment Hold a Considerable Stake in Global Chemiluminescence Immunoassay (CLIA) Analyzers Market In terms of application, the global CLIA analyzers market has been segmented into oncology, endocrine disorders, autoimmunity, hepatitis and retrovirus, infectious diseases, cardiovascular disorders, allergy, drug discovery and others. Endocrine application segment led the market in 2021 and it expected to maintain its lead during the estimate period. The ELISA Kits and Reagents Segment is Predictable to Gather Major Share of the Global CLIA Marketplace Increasing prevalence of infectious diseases like HIV, intensifying awareness for diagnosis of autoimmune diseases and cancer and advent of the coronavirus epidemic are the influences leading to the development of this segment. High-throughput COVID-19 serology testing is essential for epidemiological surveillance and most common technique for measuring antibody titers is enzyme-linked immunosorbent assay (ELISA). Though ELISA has many advantages, it is a laborious and time taking procedure with a higher probability of technical errors compared with automated platforms. In order to resolve these issues, researchers have developed automated chemiluminescent enzyme immunoassay system AIA-CL1200 to develop a serodiagnostic test that quantitatively identifies SARS-CoV-2 antibody titers. North America Dominated the Market and Garnered around 41% Share in 2021 of the Total CLIA Market Important factors boosting the regional market are existence of developed healthcare infrastructure, high implementation of technologically progressive CLIA solutions, and the snowballing prevalence of chronic diseases. Noteworthy average selling prices of automated chemiluminescence immunoassay analyzers, increasing need from surgeons for cutting-edge diagnostic instruments with improved precision and fortunate coverage as per the Clinical Laboratory Improvement Amendments for in-vitro diagnostic procedures are further bolstering the market growth. Key Company Market Insights: A foremost technological trend detected in the global chemiluminescence immunoassay analyzers market is the emergence of next-generation integrated immunoassays. For example, in October 2017, Abbott declared the FDA 510(k) clearance for Alinity ci-series, instruments for clinical chemistry and immunoassay diagnostics. This invention in multiplexed assays is prospective to push the development of global CLIA analyzers market during years to come. Some of the protuberant companies contending in the global Chemiluminescence Immunoassay marketspace are: Abbott Laboratories DiaSorin S.p.A. Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Ortho Clinical Diagnostics Siemens Healthineers Beckman Coulter Inc. F. Hoffmann-La Roche AG Inova Diagnostics, Inc. Maccura Biotechnology Co., Ltd. Immunodiagnostic Systems This research report classifies Chemiluminescence Immunoassay market as follows: By Product Type Analysis and Outlook (2016-2030) Consumables Instruments o Automated o Semi-automated Software & Services By Sample Type Analysis and Outlook (2016-2030) Oncology Therapeutic Drug Monitoring Autoimmune Disease Cardiology Endocrinology Infectious Disease Others By End-Users Analysis and Outlook (2016-2030) Hospitals Laboratories Pharmaceutical & Biotechnology Companies Others By Regional Analysis and Outlook (2016-2030) North America o U.S. o Canada Europe o Germany o United Kingdom o France o Italy o Spain o Rest of Europe Asia Pacific o China o Japan o India o Southeast Asia o South Korea o Rest of Asia Pacific Latin America o Brazil o Mexico o Rest of Latin America Middle East & Africa (MEA) o GCC o South Africa o Israel o Rest of Middle East & Africa Crucial research report study objectives: Investigate global market manufacturers, financial overview, market stake, current market activities for market-entry strategies and efficient ways to withstand competition Assess global and key regional market latent and opportunity, challenge and risks analysis Progress and improve product development, sales and marketing strategies Assess upstream raw material procurement trend and downstream buyers analysis, production process analysis Country-wise and cross segment analysis
Table of Contents
Chapter 1 Research Scope and Methodology 1.1 Report Description and Scope 1.2 Research Methodology 1.2.1 Market Research Process 1.2.2 Market Research Methodology 1.2.3 Research Tools and Models 1.3 Scope of the Study Chapter 2 Executive Summary 2.1 Chemiluminescence immunoassay (CLIA) Market Overview 2.1.1 Global Chemiluminescence immunoassay (CLIA) Market Size Analysis and Outlook (2016-2030) Chapter 3 Market Overview and Scope 3.1 Introduction of Chemiluminescence immunoassay (CLIA) 3.2 Classification and Scope 3.3 Industry Value Chain Analysis 3.3.1 Raw Material Procurement Assessment 3.3.2 Sales and Distribution Channel Scrutiny 3.3.3 Downstream Buyers Valuation 3.4 PESTEL Analysis Chapter 4 COVID 19 Impact on Chemiluminescence immunoassay (CLIA) Market 4.1 COVID-19 Pandemic Impact on: Chemiluminescence immunoassay (CLIA) Market 4.2 Pre-Covid-19 Vs Post Covid-19 - Market Estimates, 2020 2021 (US$ Bn) 4.1 Covid-19 landscape: Major Government Policy 4.2 COVID 19 - Impact Analysis for the Healthcare Industry 4.3 Market Growth Prospects and Strategies in the COVID-19 Pandemic Chapter 5 Market Impact Factors and Dynamics 5.1 Factors Governing Chemiluminescence immunoassay (CLIA) Market 5.1.1 Market Drivers 5.1.1.1 Driver Impact Analysis 5.1.1.2 Driver 1 5.1.1.3 Driver 2 5.1.1.4 Driver 3 5.1.2 Market Restraints 5.1.2.1 Industry Pitfall Impact Analysis 5.1.2.2 Restraint 1 5.1.2.3 Restraint 2 5.1.3 Market Growth Opportunities 5.1.3.1 Opportunity 1 5.1.3.2 Opportunity 2 5.2 Porters Five Forces Analysis Chapter 6 Competitive Insights 6.1 Company Market Stake Assessment 6.2 Global Chemiluminescence immunoassay (CLIA) Market Revenue (US$ Million) Analysis by Company (2015-2020) 6.3 Major Business Growth Strategies Implemented by Market Players _Toc80136350 6.4 Significant Industry Measures (Mergers, Acquisitions, Collaborations, Launch & Approvals) 6.5 Vendor Landscape 6.5.1 List of Suppliers 6.5.2 List of Buyers Chapter 7 Chemiluminescence immunoassay (CLIA) Market Analysis and Forecast by Product Type 7.1 Chemiluminescence immunoassay (CLIA) Market Analysis and Forecasts by Product Type, 2016-2030 7.1.1 Chemiluminescence immunoassay (CLIA) Market, by Product Type Analysis, 2016-2030 7.1.2 Consumables 7.1.2.1 Consumables Market Revenue Analysis and Forecast, By Region, 2016 - 2030 (US$ Mn) 7.1.3 Instruments 7.1.3.1 Instruments Market Revenue Analysis and Forecast, By Region, 2016 - 2030 (US$ Mn) 7.1.4 Software & Services 7.1.4.1 Software & Services Market Revenue Analysis and Forecast, By Region, 2016 - 2030 (US$ Mn) 7.1.5 Chemiluminescence immunoassay (CLIA) Market, Revenue Share (%) Analysis by Product Type, 2016-2020 7.1.6 Chemiluminescence immunoassay (CLIA) Market Revenue Share (%) Forecast, by Instruments021-2030 Chapter 8 Chemiluminescence immunoassay (CLIA) Market Analysis and Forecast by Application 8.1 Chemiluminescence immunoassay (CLIA) Market Analysis and Forecasts by Application, 2016-2030 8.1.1 Chemiluminescence immunoassay (CLIA) Market, by Application Analysis, 2016-2030 8.1.2 Oncology 8.1.2.1 Oncology Market Revenue Analysis and Forecast, By Region, 2016 - 2030 (US$ Mn) 8.1.3 Therapeutic Drug Monitoring 8.1.3.1 Therapeutic Drug Monitoring Market Revenue Analysis and Forecast, By Region, 2016 - 2030 (US$ Mn) 8.1.4 Autoimmune Disease 8.1.4.1 Autoimmune Disease Market Revenue Analysis and Forecast, By Region, 2016 - 2030 (US$ Mn) Chapter 9 Global Chemiluminescence immunoassay (CLIA) Market Analysis and Outlook by Region 9.1 Global Chemiluminescence immunoassay (CLIA) Market Analysis and Outlook by Regions (2016-2030) 9.1.1 Global Chemiluminescence immunoassay (CLIA) Market Revenue and Forecast (2016-2030) 9.2.1 Chemiluminescence immunoassay (CLIA) Market Size and Growth rate Comparison, by Region, 2016-2030 9.2.2 Global Chemiluminescence immunoassay (CLIA) Market Size Comparison by Regions (2016-2030) 9.2.3 North America Chemiluminescence immunoassay (CLIA) Market Revenue and Forecast (2016-2030) 9.2.4 North America Chemiluminescence immunoassay (CLIA) Market Revenue, Consumption and Forecast, by country (2016-2030) 9.2.4.1 US Chemiluminescence immunoassay (CLIA) Market Revenue and Forecast (2016-2030) 9.2.4.2 Canada Chemiluminescence immunoassay (CLIA) Market Revenue and Forecast (2016-2030) 9.2.5 Europe Chemiluminescence immunoassay (CLIA) Market Revenue and Forecast (2016-2030) 9.2.6 Europe Chemiluminescence immunoassay (CLIA) Market Revenue, Consumption and Forecast, by country (2016-2030) 9.2.6.1 Germany Chemiluminescence immunoassay (CLIA) Market Revenue and Forecast (2016-2030) 9.2.6.2 UK Chemiluminescence immunoassay (CLIA) Market Revenue and Forecast (2016-2030) 9.2.6.3 France Chemiluminescence immunoassay (CLIA) Market Revenue and Forecast (2016-2030) 9.2.6.4 Italy Chemiluminescence immunoassay (CLIA) Market Revenue and Forecast (2016-2030) 9.2.6.5 Spain Chemiluminescence immunoassay (CLIA) Market Revenue and Forecast (2016-2030) 9.2.7 Asia Pacific Chemiluminescence immunoassay (CLIA) Market Revenue and Forecast (2016-2030) 9.2.8 Asia Pacific Chemiluminescence immunoassay (CLIA) Market Revenue, Consumption and Forecast, by country (2016-2030) 9.2.8.1 China Chemiluminescence immunoassay (CLIA) Market Revenue and Forecast (2016-2030) 9.2.8.2 Japan Chemiluminescence immunoassay (CLIA) Market Revenue and Forecast (2016-2030) 9.2.8.3 India Chemiluminescence immunoassay (CLIA) Market Revenue and Forecast (2016-2030) 9.2.8.4 South Korea Chemiluminescence immunoassay (CLIA) Market Revenue and Forecast (2016-2030) 9.2.8.5 Southeast Asia Chemiluminescence immunoassay (CLIA) Market Revenue and Forecast (2016-2030) 9.2.9 Latin America Chemiluminescence immunoassay (CLIA) Market Revenue and Forecast (2016-2030) 9.2.10 Latin America Chemiluminescence immunoassay (CLIA) Market Revenue, Consumption and Forecast, by country (2016-2030) 9.2.10.1 Mexico Chemiluminescence immunoassay (CLIA) Market Revenue and Forecast (2016-2030) 9.2.10.2 Brazil Chemiluminescence immunoassay (CLIA) Market Revenue and Forecast (2016-2030) 9.2.11 Middle East and Africa Chemiluminescence immunoassay (CLIA) Market Revenue and Forecast (2016-2030) 9.2.12 Middle East and Africa Chemiluminescence immunoassay (CLIA) Market Revenue, Consumption and Forecast, by country (2016-2030) 9.2.12.1 GCC Chemiluminescence immunoassay (CLIA) Market Revenue and Forecast (2016-2030) 9.2.12.2 South Africa Chemiluminescence immunoassay (CLIA) Market Revenue and Forecast (2016-2030) 9.2.12.3 Israel Chemiluminescence immunoassay (CLIA) Market Revenue and Forecast (2016-2030) Chapter 10 Global Chemiluminescence immunoassay (CLIA) Market, Regional Analysis and Trend Outlook 10.1 North America 10.1.1 U.S. 10.1.1.1 U.S. Chemiluminescence immunoassay (CLIA) Market Revenue (US$ Million) by Product Type (2016-2030) 10.1.2 Canada 10.1.2.1 Canada Chemiluminescence immunoassay (CLIA) Market Revenue (US$ Million) by Product Type (2016-2030) 10.2 Europe 10.2.1 Germany 10.2.1.1 Germany Chemiluminescence immunoassay (CLIA) Market Revenue (US$ Million) by Product Type (2016-2030) 10.2.2 UK 10.2.2.1 UK Chemiluminescence immunoassay (CLIA) Market Revenue (US$ Million) by Product Type (2016-2030) 10.2.3 France 10.2.3.1 France Chemiluminescence immunoassay (CLIA) Market Revenue (US$ Million) by Product Type (2016-2030) 10.2.4 Italy 10.2.4.1 Italy Chemiluminescence immunoassay (CLIA) Market Revenue (US$ Million) by Product Type (2016-2030) 10.2.5 Spain 10.2.5.1 Spain Chemiluminescence immunoassay (CLIA) Market Revenue (US$ Million) by Product Type (2016-2030) 10.3 Asia Pacific 10.3.1 China 10.3.1.1 China Chemiluminescence immunoassay (CLIA) Market Revenue (US$ Million) by Product Type (2016-2030) 10.3.2 Japan 10.3.2.1 Japan Chemiluminescence immunoassay (CLIA) Market Revenue (US$ Million) by Product Type (2016-2030) 10.3.3 India 10.3.3.1 India Chemiluminescence immunoassay (CLIA) Market Revenue (US$ Million) by Product Type (2016-2030) 10.3.4 South Korea 10.3.4.1 South Korea Chemiluminescence immunoassay (CLIA) Market Revenue (US$ Million) by Product Type (2016-2030) 10.3.5 Southeast Asia 10.3.5.1 Southeast Asia Chemiluminescence immunoassay (CLIA) Market Revenue (US$ Million) by Product Type (2016-2030) 10.4 Latin America 10.4.1 Mexico 10.4.1.1 Mexico Chemiluminescence immunoassay (CLIA) Market Revenue (US$ Million) by Product Type (2016-2030) 10.4.2 Brazil 10.4.2.1 Brazil Chemiluminescence immunoassay (CLIA) Market Revenue (US$ Million) by Product Type (2016-2030) 10.5 Latin America 10.5.1 GCC 10.5.1.1 GCC Chemiluminescence immunoassay (CLIA) Market Revenue (US$ Million) by Product Type (2016-2030) 10.5.2 South Korea 10.5.2.1 South Korea Chemiluminescence immunoassay (CLIA) Market Revenue (US$ Million) by Product Type (2016-2030) 10.5.3 Israel 10.5.3.1 Israel Chemiluminescence immunoassay (CLIA) Market Revenue (US$ Million) by Product Type (2016-2030) Chapter 11 Company Profile 11.1 Abbott Laboratories 11.1.1 Company Overview 11.1.2 Business Overview 11.1.3 Product Portfolio 11.1.4 Financial Performance 11.1.5 Revenue, and Gross Margin (2015-2020) 11.1.6 Recent Developments and Growth Strategies 11.2 DiaSorin S.p.A. 11.2.1 Company Overview 11.2.2 Business Overview 11.2.3 Product Portfolio 11.2.4 Financial Performance 11.2.5 Revenue, and Gross Margin (2015-2020) 11.2.6 Recent Developments and Growth Strategies 11.3 Shenzhen Mindray Bio-Medical Electronics Co., Ltd. 11.3.1 Company Overview 11.3.2 Business Overview 11.3.3 Product Portfolio 11.3.4 Financial Performance 11.3.5 Revenue, and Gross Margin (2015-2020) 11.3.6 Recent Developments and Growth Strategies 11.4 Ortho Clinical Diagnostics 11.4.1 Company Overview 11.4.2 Business Overview 11.4.3 Product Portfolio 11.4.4 Financial Performance 11.4.5 Revenue, and Gross Margin (2015-2020) 11.4.6 Recent Developments and Growth Strategies 11.5 Siemens Healthineers 11.5.1 Company Overview 11.5.2 Business Overview 11.5.3 Product Portfolio 11.5.4 Financial Performance 11.5.5 Revenue, and Gross Margin (2015-2020) 11.5.6 Recent Developments and Growth Strategies 11.6 Beckman Coulter Inc. 11.6.1 Company Overview 11.6.2 Business Overview 11.6.3 Product Portfolio 11.6.4 Financial Performance 11.6.5 Revenue, and Gross Margin (2015-2020) 11.6.6 Recent Developments and Growth Strategies 11.7 F. Hoffmann-La Roche AG 11.7.1 Company Overview 11.7.2 Business Overview 11.7.3 Product Portfolio 11.7.4 Financial Performance 11.7.5 Revenue, and Gross Margin (2015-2020) 11.7.6 Recent Developments and Growth Strategies 11.8 Inova Diagnostics, Inc. 11.8.1 Company Overview 11.8.2 Business Overview 11.8.3 Product Portfolio 11.8.4 Financial Performance 11.8.5 Revenue, and Gross Margin (2015-2020) 11.8.6 Recent Developments and Growth Strategies 11.9 Maccura Biotechnology Co., Ltd. 11.9.1 Company Overview 11.9.2 Business Overview 11.9.3 Product Portfolio 11.9.4 Financial Performance 11.9.5 Revenue, and Gross Margin (2015-2020) 11.9.6 Recent Developments and Growth Strategies 11.10 Immunodiagnostic Systems 11.10.1 Company Overview 11.10.2 Business Overview 11.10.3 Product Portfolio 11.10.4 Financial Performance 11.10.5 Revenue, and Gross Margin (2015-2020) 11.10.6 Recent Developments and Growth Strategies 11.11 Company 11 11.11.1 Company Overview 11.11.2 Business Overview 11.11.3 Product Portfolio 11.11.4 Financial Performance 11.11.5 Revenue, and Gross Margin (2015-2020) 11.11.6 Recent Developments and Growth Strategies 11.12 Company 12 11.12.1 Company Overview 11.12.2 Business Overview 11.12.3 Product Portfolio 11.12.4 Financial Performance 11.12.5 Revenue, and Gross Margin (2015-2020) 11.12.6 Recent Developments and Growth Strategies Chapter 12 Disclaimer
Methodology
This research report involves complete picture of the market with the help of in-depth secondary and primary research. This research report studies several aspects of the market and analyze vital industry influencers. Extensive secondary research has been conducted using paid as well as open access data sources in order to gather information on the market and parent market. These key findings are then analyzed and validated with the help of in-house data models and primary discussions with key industry participants and experts across the value chain
Research Tools and Models
- Top-Down Approach and Bottom-Up Approach
- QFD Modeling for Market Size and Share Calculation
- Regression, Variable and Impact Analysis
- Penetration Modeling
Qualitative Research
- It comprises briefing about market dynamics and business opportunities and strategies.
- Finally, all the research findings are validated through interviews with in-house industry experts, freelance consultants and key opinion leaders etc.
Quantitative Research
It involves various mathematical tools, models, projection, and sampling techniques. It involves following steps:
- Identification of market variables and market size derivation
- Assessment of future prospects, opportunities and market penetration rates by analyzing product commercialization, regional trends etc.
- Evaluation historical market trends and derivation of present and future year-on-year growth trends
